Dihydrotestosterone-transdermal
Alternative Names: DHT-transdermal - BentleyLatest Information Update: 09 Mar 2010
At a glance
- Originator Bentley Pharmaceuticals
- Developer Auxilium Pharmaceuticals; Bentley Pharmaceuticals
- Class Androstanols; Testosterone congeners
- Mechanism of Action Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Male osteoporosis
Most Recent Events
- 12 Mar 2003 No development reported for Male osteoporosis in USA (Transdermal)
- 08 Aug 2001 Investigation in Male osteoporosis in USA (Transdermal)